Loading viewer...
investor_presentation
Format: PDF investor_presentation
Basilea Pharmaceutica is a commercial-stage biotech company focused on oncology and infectious diseases with two marketed hospital anti-infective brands (Cresemba and Zevtera) and three oncology candidates in development. The company emphasizes sustainable growth potential through commercialized brands, an innovative pipeline, and established partnership capabilities across development and commercial stages.
investor_presentation
26 Pages
investor_presentation
17 Pages
Unknown
investor_presentation
Arizona Lithium
investor_presentation
Diamond Foods